Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III crossover comparison of two dry powder budesonide inhalers on methacholine hyper-reactivity in moderate asthma
2005-005469-12Phase 3Completed
- Sponsor
- Neolab Limited
- Start
- Dec 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of budesonide in asthma (2 arms), sponsored by Neolab Limited. Primary endpoint: Airway responsiveness to methacholine. Started Dec 2005; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-005469-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005469-12.